Beta variant COVID-19 protein booster vaccine elicits durable cross-neutralization against SARS-CoV-2 variants in non-human primates
Waning protective efficacy of mRNA-based booster vaccinations has been observed against newly emerging SARS-CoV-2 variants of concern. In this work, Pavot et al. formulate a monovalent Beta vaccine and demonstrate durable cross-neutralising antibody responses in non-human primates, against a spectru...
Full description
Bibliographic Details
| Main Authors: |
Vincent Pavot,
Catherine Berry,
Michael Kishko,
Natalie G. Anosova,
Lu Li,
Tim Tibbitts,
Dean Huang,
Alice Raillard,
Sylviane Gautheron,
Cindy Gutzeit,
Marguerite Koutsoukos,
Roman M. Chicz,
Valerie Lecouturier |
|---|
| Format: | Article
|
|---|
| Language: | English |
|---|
| Published: |
Nature Portfolio
2023-03-01
|
|---|
| Series: | Nature Communications
|
|---|
| Online Access: | https://doi.org/10.1038/s41467-023-36908-z
|
|---|